where does hers get their semaglutide Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis Hims & Hers down as

What are the main side effects

Other medications that can facilitate weight loss in T2D, notably the SGLT2 inhibitors, may prove more acceptable and better tolerated than GLP-1 RAs

Enhanced phosphatase activity attenuates alpha-synucleinopathy in a mouse model

Sharma A, Mollier J, Brocklesby RWK, Caves C, Jayasena CN, Minhas S

2 The addition of semaglutide to the Food and Drug Administration (FDA) shortage list from 2022 to February 2025, and tirzepatide to the same list from 2022 to December 2024, gave compounding pharmacies permission by the FDA to produce exact duplicates to ensure continuity of treatment until production met demand

Improved reaction dynamics: Instead of applying the brute force of highly reactive chemicals, enzyme-based peptide synthesis allows manufacturers to trigger highly specific reactions under optimized conditions